Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014 (2014), Article ID 178049, 9 pages
http://dx.doi.org/10.1155/2014/178049
Research Article

The Inhibitory Effect of PIK-75 on Inflammatory Mediator Response Induced by Hydrogen Peroxide in Feline Esophageal Epithelial Cells

1Signaling and Pharmacological Activity Research Lab, College of Pharmacy, Chung-Ang University, Seoul 156-756, Republic of Korea
2Host Defense Modulation Lab, College of Pharmacy, Chung-Ang University, Seoul 156-756, Republic of Korea

Received 16 May 2014; Accepted 30 July 2014; Published 7 September 2014

Academic Editor: Sandra Helena Penha Oliveira

Copyright © 2014 Jun Yeong Jeong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Toker and S. Marmiroli, “Signaling specificity in the Akt pathway in biology and disease,” Advances in Biological Regulation, vol. 55, pp. 28–38, 2014. View at Publisher · View at Google Scholar
  2. J. A. Engelman, J. Luo, and L. C. Cantley, “The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism,” Nature Reviews Genetics, vol. 7, no. 8, pp. 606–619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Vanhaesebroeck, S. J. Leevers, K. Ahmadi et al., “Synthesis and function of 3-phosphorylated inositol lipids,” Annual Review of Biochemistry, vol. 70, pp. 535–602, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Osaki, M. Oshimura, and H. Ito, “PI3K-Akt pathway: its functions and alterations in human cancer,” Apoptosis, vol. 9, no. 6, pp. 667–676, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Iizuka and S. Konno, “Wound healing of intestinal epithelial cells,” World Journal of Gastroenterology, vol. 17, no. 17, pp. 2161–2171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. T. L. Yuan and L. C. Cantley, “PI3K pathway alterations in cancer: variations on a theme,” Oncogene, vol. 27, no. 41, pp. 5497–5510, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Samuels, Z. Wang, A. Bardelli et al., “High frequency of mutations of the PIK3CA gene in human cancers,” Science, vol. 304, no. 5670, p. 554, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Fougerat, S. Gayral, N. Malet, F. Briand-Mesange, M. Breton-Douillon, and M. Laffargue, “Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?” Clinical Science, vol. 116, no. 11-12, pp. 791–804, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Denley, S. Kang, U. Karst, and P. K. Vogt, “Oncogenic signaling of class I PI3K isoforms,” Oncogene, vol. 27, no. 18, pp. 2561–2574, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Ghigo, F. Damilano, L. Braccini, and E. Hirsch, “PI3K inhibition in inflammation: toward tailored therapies for specific diseases,” BioEssays, vol. 32, no. 3, pp. 185–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Rasul, M. Khan, B. Yu et al., “Isoalantolactone, a sesquiterpene lactone, induces apoptosis in SGC-7901 cells via mitochondrial and phosphatidylinositol 3-kinase/Akt signaling pathways,” Archives of Pharmacal Research, vol. 36, no. 10, pp. 1262–1269, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Vanhaesebroeck, S. J. Leevers, G. Panayotou, and M. D. Waterfield, “Phosphoinositide 3-kinases: a conserved family of signal transducers,” Trends in Biochemical Sciences, vol. 22, no. 7, pp. 267–272, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. L. E. Rameh and L. C. Cantley, “The role of phosphoinositide 3-kinase lipid products in cell function,” The Journal of Biological Chemistry, vol. 274, no. 13, pp. 8347–8350, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Duronio, “The life of a cell: apoptosis regulation by the PI3K/PKB pathway,” The Biochemical Journal, vol. 415, no. 3, pp. 333–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. T. F. Franke, “PI3K/Akt: getting it right matters,” Oncogene, vol. 27, no. 50, pp. 6473–6488, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Zhao and P. K. Vogt, “Class I PI3K in oncogenic cellular transformation,” Oncogene, vol. 27, no. 41, pp. 5486–5496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Engelman, “Targeting PI3K signalling in cancer: opportunities, challenges and limitations,” Nature Reviews Cancer, vol. 9, no. 8, pp. 550–562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Blajecka, A. Borgström, and A. Arcaro, “Phosphatidylinositol 3-kinase isoforms as novel drug targets,” Current Drug Targets, vol. 12, no. 7, pp. 1056–1081, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Janku, J. J. Wheler, S. N. Westin et al., “PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations,” Journal of Clinical Oncology, vol. 30, no. 8, pp. 777–782, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. K. D. Courtney, R. B. Corcoran, and J. A. Engelman, “The PI3K pathway as drug target in human cancer,” Journal of Clinical Oncology, vol. 28, no. 6, pp. 1075–1083, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. J. Harris, J. G. Foster, and S. G. Ward, “PI3K isoforms as drug targets in inflammatory diseases: lessons from pharmacological and genetic strategies,” Current Opinion in Investigational Drugs, vol. 10, no. 11, pp. 1151–1162, 2009. View at Google Scholar · View at Scopus
  22. D. C. Baumgart and W. J. Sandborn, “Inflammatory bowel disease: clinical aspects and established and evolving therapies,” The Lancet, vol. 369, no. 9573, pp. 1641–1657, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Babu, D. Thapa, J. S. Lee et al., “Inhibitory effects of an aqueous extract of Cornus kousa Burg. Leaves on TNF-α-induced chemokine expression and monocyte adhesion to human colonic epithelial cells,” Archives of Pharmacal Research, vol. 32, no. 1, pp. 91–98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. H. Choi, Y. L. Su, and B. P. Won, “Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Akt,” Archives of Pharmacal Research, vol. 27, no. 1, pp. 68–76, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Yoshida and T. Yoshikawa, “Defense mechanism of the esophageal mucosa and esophageal inflammation,” Journal of Gastroenterology, vol. 38, supplement 15, pp. 31–34, 2003. View at Google Scholar · View at Scopus
  26. N. Yoshida, K. Uchiyama, M. Kuroda et al., “Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease,” Scandinavian Journal of Gastroenterology, vol. 39, no. 9, pp. 816–822, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Isomoto, A. Wang, Y. Mizuta et al., “Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis,” The American Journal of Gastroenterology, vol. 98, no. 3, pp. 551–556, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Fischer, M. Wiesnet, D. Renz, and W. Schaper, “H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway,” European Journal of Cell Biology, vol. 84, no. 7, pp. 687–697, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Olyaee, S. Sontag, W. Salman et al., “Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus,” Gut, vol. 37, no. 2, pp. 168–173, 1995. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Rieder, P. Biancani, K. Harnett, L. Yerian, and G. W. Falk, “Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 298, no. 5, pp. G571–G581, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Cao, K. M. Harnett, L. Cheng, M. T. Kirber, J. Behar, and P. Biancani, “H2O2: a mediator of esophagitis-induced damage to calcium-release mechanisms in cat lower esophageal sphincter,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 288, no. 6, pp. G1170–G1178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Zheng, S. I. Amran, P. E. Thompson, and I. G. Jennings, “Isoform-selective inhibition of phosphoinositide 3-kinase: identification of a new region of nonconserved amino acids critical for p110α inhibition,” Molecular Pharmacology, vol. 80, no. 4, pp. 657–664, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. J. C. Lim, S. Y. Park, Y. Nam, T. T. Nguyen, and U. D. Sohn, “The protective effect of eupatilin against hydrogen peroxide-induced injury involving 5-lipoxygenase in feline esophageal epithelial cells,” Korean Journal of Physiology and Pharmacology, vol. 16, no. 5, pp. 313–320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Braccini, E. Ciraolo, M. Martini et al., “PI3K keeps the balance between metabolism and cancer,” Advances in Biological Regulation, vol. 52, no. 3, pp. 389–405, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Pal, M. Fulciniti, P. Nanjappa et al., “Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth,” Cancer Genomics & Proteomics, vol. 9, no. 2, pp. 55–66, 2012. View at Google Scholar · View at Scopus
  36. H. Isomoto, Y. Nishi, Y. Kanazawa et al., “Immune and inflammatory responses in GERD and lansoprazole,” Journal of Clinical Biochemistry and Nutrition, vol. 41, no. 2, pp. 84–91, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. C. A. Dinarello and R. C. Thompson, “Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro,” Immunology Today, vol. 12, no. 11, pp. 404–410, 1991. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Rieder, L. Cheng, K. M. Harnett et al., “Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities,” Gastroenterology, vol. 132, no. 1, pp. 154–165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Cao, L. Cheng, J. Behar, C. Fiocchi, P. Biancani, and K. M. Harnett, “Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 287, no. 6, pp. G1131–G1139, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Beauséjour, D. Noël, S. Thibodeau et al., “Integrin/Fak/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: selective engagement and roles of PI3-K isoform complexes,” Apoptosis, vol. 17, no. 6, pp. 566–578, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. Z. A. Knight, B. Gonzalez, M. E. Feldman et al., “A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling,” Cell, vol. 125, no. 4, pp. 733–747, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Li, J. Song, M. G. Cassidy et al., “Pi3K p110α/Akt signaling negatively regulates secretion of the intestinal peptide neurotensin through interference of granule transport,” Molecular Endocrinology, vol. 26, no. 8, pp. 1380–1393, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Talekar, S. Ganta, M. Amiji et al., “Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy,” International Journal of Pharmaceutics, vol. 450, no. 1-2, pp. 278–289, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Talekar, J. Kendall, W. Denny, S. Jamieson, and S. Garg, “Development and evaluation of PIK75 nanosuspension, a phosphatidylinositol-3-kinase inhibitor,” European Journal of Pharmaceutical Sciences, vol. 47, no. 5, pp. 824–833, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Carvalho, F. Milanezi, J. L. Costa, I. Amendoeira, and F. Schmitt, “PIKing the right isoform: the emergent role of the p110β subunit in breast cancer,” Virchows Archiv, vol. 456, no. 3, pp. 235–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Yoshida, E. Imamoto, K. Uchiyama et al., “Molecular mechanisms involved in interleukin-8 production by normal human oesophageal epithelial cells,” Alimentary Pharmacology and Therapeutics, vol. 24, no. 4, pp. 219–226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. J. M. O'Riordan, M. M. Abdel-Latif, N. Ravi et al., “Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus,” The American Journal of Gastroenterology, vol. 100, no. 6, pp. 1257–1264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Yoshida, “Inflammation and oxidative stress in gastroesophageal reflux disease,” Journal of Clinical Biochemistry and Nutrition, vol. 40, no. 1, pp. 13–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Eda, B. L. Burnette, H. Shimada, H. R. Hope, and J. B. Monahan, “Interleukin-1β-induced interleukin-6 production in A549 cells is mediated by both phosphatidylinositol 3-kinase and interleukin-1 receptor-associated kinase-4,” Cell Biology International, vol. 35, no. 4, pp. 355–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. C. M. Cahill and J. T. Rogers, “Interleukin (IL) 1β induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IκB kinase α pathway targeting activator protein-1,” Journal of Biological Chemistry, vol. 283, no. 38, pp. 25900–25912, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. S. I. Gharbi, M. J. Zvelebil, S. J. Shuhleworth et al., “Exploring the specificity of the PI3K family inhibitor LY294002,” The Biochemical Journal, vol. 404, no. 1, pp. 15–21, 2007. View at Publisher · View at Google Scholar · View at Scopus